BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37385966)

  • 21. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
    Shen R; Deng W; Li C; Zeng G
    Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
    Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
    Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
    Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.
    Acharya S; Timilshina M; Jiang L; Neupane S; Choi DY; Park SW; Lee SY; Jeong BS; Kim JA; Nam TG; Chang JH
    Sci Rep; 2018 May; 8(1):7799. PubMed ID: 29773813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
    Dang C; Lu Y; Chen X; Li Q
    Front Immunol; 2021; 12():650708. PubMed ID: 33927721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
    Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
    Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 9,10-Anhydrodehydroartemisinin Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Th1 and Th17 Cell Differentiation.
    Lv J; Zhuang W; Zhang Y; Xie L; Xiang Z; Zhao Q; Jiang X; Shen J; Du C
    Inflammation; 2021 Oct; 44(5):1793-1802. PubMed ID: 33788130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
    Saxena N; Won J; Choi S; Singh AK; Singh I
    Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
    Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
    Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Aqueous Extract of Tarragon on Clinical Symptoms and T Cell Differentiation in Experimental Autoimmune Encephalomyelitis.
    Nowras T; Fereidouni M; Safari H; Naseri M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):523-532. PubMed ID: 32245296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
    Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
    Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progranulin Suppressed Autoimmune Uveitis and Autoimmune Neuroinflammation by Inhibiting Th1/Th17 Cells and Promoting Treg Cells and M2 Macrophages.
    Wang C; Zhou W; Su G; Hu J; Yang P
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35082168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BTN2A2-Ig protein inhibits the differentiation of pathogenic Th17 cells and attenuates EAE in mice.
    Huang Y; Han F; Li J; Li Y; Gao J; Lai L; Luo P; Su M; Hu R
    Immunol Lett; 2023 Aug; 260():58-67. PubMed ID: 37369312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
    Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
    Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
    Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
    Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnolol as STAT3 inhibitor for treating multiple sclerosis by restricting Th17 cells.
    Chen JY; Tian XY; Wei SS; Xu W; Pan RR; Chen LL; Chen LD; Nan LH; Yao-Lin ; Shan-Deng ; Wang QQ; Ma XQ; Huang MQ
    Phytomedicine; 2023 Aug; 117():154917. PubMed ID: 37301184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.